A phase I clinical pharmacology study of SJP-0135

Trial Profile

A phase I clinical pharmacology study of SJP-0135

Phase of Trial: Phase I

Latest Information Update: 12 Mar 2018

At a glance

  • Drugs SJP 0135 (Primary) ; Brimonidine; Timolol
  • Indications Ocular hypertension; Open-angle glaucoma
  • Focus Pharmacokinetics
  • Sponsors Senju Pharmaceutical
  • Most Recent Events

    • 07 Mar 2018 Status changed from not yet recruiting to completed.
    • 04 Oct 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top